Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Analogues of hepcidin mimetics with improved in vivo half lives

Analogues of hepcidin mimetics with improved in vivo half lives

US Patent 11472842 · Granted Oct 18, 2022

Estimated economic value: $7,175,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipidated peptide inhibitors of interleukin-23 receptor2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Hepcidin analogues and uses thereof2025
Hepcidin analogues and uses thereof2025
Hepcidin analogues and uses thereof2025
Conjugated hepcidin mimetics2025
Conjugated hepcidin mimetics2025
Conjugated hepcidin mimetics2025
Conjugated hepcidin mimetics2025
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Compositions of peptide inhibitors of Interleukin-23 receptor2024